Scandion Oncology (OMX: SCOL)

Last close As at 20/05/2024

1.36

−0.03 (−2.16%)

Market capitalisation

SEK56m

Latest Insights

View More

Share Price Performance

Price Performance
% 1M 3M 12M
Actual (11.6) (39.0) (84.4)
Relative (9.5) (41.4) (86.2)
52 week high/low SEK8.7/SEK1.4

Financials

Edison Investment Research is terminating coverage on Scandion Oncology (SCOL). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.

Y/E Dec Revenue (DKKm) EBITDA (DKKm) PBT (DKKm) EPS (ore) P/E (x) P/CF (x)
2021A 0.8 (54.8) (57.2) (161.0) N/A N/A
2022A 2.1 (79.3) (82.2) (187.0) N/A N/A
2023E 0.6 (65.3) (65.3) (147.0) N/A N/A
2024E 0.6 (69.0) (69.4) (157.0) N/A N/A

Thematics

thematic

Investment Companies

UK stock market – Scope for further upside in UK large-cap stocks

thematic

Investment Companies

Listed private equity – Performing a balancing act

thematic

Consumer

ConsumerWatch – At least someone loves me

thematic

TMT

MediaWatch – Rinse and repeat

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free